Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Fears about AI data centers’ water use have exploded. Experts say the reality is far more complicated than people think. When I called him to talk more about AI and water, Masley emphasized that he’s ...

Windows 10 still powers over two in five active desktops worldwide Enterprises delay upgrades through paid security extensions for critical systems Consumers keep older PCs active for light tasks and ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Wirecutter Staff No matter ...

Many popular apps collect more of your personal data than necessary to function properly. These 20 apps quietly scoop up your photos, location, contacts, and more. Here's how to protect yourself. I ...

To maintain a healthy credit score, it's important to keep your credit utilization rate (CUR) low. The general rule of thumb has been that you don't want your CUR to exceed 30%, but increasingly ...

As a nationally recognized personal finance writer for the past decade, Jacob Wade has written professionally about banking and other consumer topics for Investopedia, Money.com, The Balance, ...